Top-Quality Fluoxymesterone(Halotestin)Powder For Bodybuilding CAS:76-43-7

   The Compound's Identity

    Fluoxymesterone, most widely recognized by its brand name Halotestin, occupies a peculiar and highly specialized niche within the landscape of performance-enhancing compounds. First synthesized in the 1950s and approved by the FDA in 1956, this oral anabolic-androgenic steroid (AAS) was developed by Pharmacia & Upjohn and initially intended for legitimate medical applications including male hypogonadism, delayed puberty, breast cancer in women, and anemia Unlike many of its counterparts that found widespread adoption across various athletic disciplines, Fluoxymesterone never achieved mainstream popularity in bodybuilding circles. Instead, it earned a reputation as a "niche" compound-one pursued almost exclusively by athletes chasing very specific, narrowly defined outcomes

    The raw powder form of Fluoxymesterone, which serves as the active pharmaceutical ingredient for tablet manufacturing, presents as a white or nearly white, odorless, crystalline substance. Its melting point falls at approximately 228–240°C, with some decomposition occurring at the higher end of this range.The compound carries the molecular formula C₂₀H₂₉FO₃ and a molecular weight of 336.44 g/mol. It is practically insoluble in water, sparingly soluble in alcohol, and slightly soluble in chloroform-physical characteristics that inform its formulation and oral administration route.

    What distinguishes Fluoxymesterone from many other anabolic steroids is its status as a 17α-alkylated derivative of testosterone. This structural modification-the addition of a methyl group at the 17-alpha position-serves a critical purpose: it allows the compound to survive first-pass hepatic metabolism when taken orally.Without this alkylation, oral bioavailability would be negligible. Yet this very feature that enables oral administration also underpins the compound's well-documented hepatotoxic profile, a trade-off that has shaped its usage patterns and reputation.

    The pharmacological signature of Fluoxymesterone sets it apart from virtually every other compound in the AAS class. Perhaps most significantly, it is a non-aromatizing steroid. It does not convert to estrogen through the aromatase enzyme pathway, meaning users experience none of the estrogenic side effects associated with many other steroids-no water retention, no gynecomastia, no bloating.For athletes competing in weight-class sports or those who require a dry, hard, vascular appearance on stage, this characteristic is invaluable. The absence of water retention means weight gain from the compound is strictly lean tissue, and competitors need not worry about blurring their muscular definition in the days leading up to a show or weigh-in.The compound exhibits a remarkably high ratio of androgenic to anabolic activity. In practical terms, this means its effects skew heavily toward androgenic outcomes-increased aggression, enhanced central nervous system stimulation, and profound strength gains-rather than the tissue-building, anabolic effects that characterize compounds like Dianabol or Anadrol. Some sources indicate Fluoxymesterone is approximately five to ten times more potent than testosterone on a milligram-for-milligram basis, while others suggest it is roughly ten times more potent than methyltestosterone.

    The compound's mechanism of action, while fundamentally rooted in androgen receptor (AR) binding, presents some intriguing nuances.Fluoxymesterone functions as an androgen receptor agonist, binding to AR sites throughout the body and initiating the cascade of effects characteristic of androgenic stimulation. However, the binding affinity is relatively low compared to some other AAS compounds.Some researchers have suggested that a significant portion of its effects may be non-AR mediated.potentially involving alternative pathways such as glucocorticoid receptor antagonism. This may help explain why Fluoxymesterone delivers such pronounced strength and aggression benefits despite what appears to be modest receptor binding.

    The pharmacokinetic profile of Fluoxymesterone is another area where common misconceptions abound. A persistent rumor circulating in bodybuilding circles suggests the compound has an extremely short half-life of merely 30 to 90 minutes. This is demonstrably incorrect. The actual elimination half-life of Fluoxymesterone after oral administration is approximately 9.2 to 9.5 hours.This longer half-life has practical implications for dosing frequency and cycle planning-while some users still split their daily dosage into two administrations to maintain stable blood levels, the pharmacokinetic reality suggests once-daily dosing may be sufficient for many applications.

    Oral bioavailability is reportedly high, approaching 80 to 100 percent.Metabolism occurs primarily in the liver,with excretion occurring through the urinary route.The compound produces several metabolites, including 5α-dihydrofluoxymesterone and 11-oxofluoxymesterone,which may contribute to its overall activity profile.

    The application of Fluoxymesterone in bodybuilding differs markedly from its use in other athletic disciplines, and understanding this distinction is crucial for anyone considering the compound. In the broader athletic world-particularly among powerlifters, strongman competitors, and combat sports athletes like boxers and MMA fighters-Halotestin is valued primarily for its ability to produce rapid, dramatic increases in raw strength and aggression. These athletes typically employ the compound in the immediate lead-up to competition, where the strength enhancement can provide a tangible competitive edge.

    For bodybuilders, however, the applications are more nuanced. The compound is almost exclusively utilized during the cutting phase or pre-contest preparation, when the primary objectives are preserving lean muscle mass while in a caloric deficit, achieving a dry, hard, vascular appearance, and maintaining training intensity despite reduced carbohydrate intake. Fluoxymesterone is not considered a bulking agent; users attempting to pack on substantial muscle mass with this compound are typically disappointed. Its value lies not in tissue accretion but in the quality of the tissue retained and the performance enhancement it enables during the most demanding phases of preparation.

    The anti-estrogenic properties of Fluoxymesterone further enhance its utility during contest preparation. By preventing estrogen conversion, the compound helps athletes achieve the dry, shredded look that judges reward. Water retention is minimized, muscle definition is sharpened, and the risk of estrogen-related side effects is eliminated entirely.

    The benefits of Fluoxymesterone, while narrow in scope, are substantial within their domain. The most frequently cited and universally acknowledged benefit is dramatic strength enhancement. Users routinely report strength increases that outpace what they achieve with any other compound, often within days of initiating a cycle. This is not the gradual, cumulative strength gain associated with long-term testosterone therapy or the steady progression from compounds like equipoise. This is rapid, pronounced, and unmistakable.

    The compound also delivers meaningful improvements in aggression and focus. This is not merely psychological; the androgenic stimulation of the central nervous system produces a state of heightened arousal and competitive intensity that can translate directly into improved training performance. For athletes who struggle to maintain intensity during the later stages of a cut-when energy is depleted and motivation wanes-this effect can be particularly valuable.

    Lean muscle preservation during caloric restriction is another documented benefit. Fluoxymesterone promotes nitrogen retention and protein anabolism while decreasing protein catabolism, creating a metabolic environment that favors muscle preservation even when the body is in a deficit. This is the primary reason bodybuilders turn to the compound during contest preparation.

    Fat loss is also promoted through increased metabolic rate, and the absence of estrogenic water retention ensures that any fat lost translates directly into visible improvements in muscular definition. For competitors stepping on stage, this is invaluable.

    The compound's ability to enhance red blood cell production through stimulation of erythropoietic factors may also contribute to improved endurance and recovery, though this effect is secondary to the primary strength and aggression benefits.

    Determining appropriate Fluoxymesterone dosage requires careful consideration of experience level, goals, and risk tolerance. The compound's potency demands respect, and dosing should always err on the conservative side, particularly for first-time users.

    For beginners, daily dosages in the range of 10 to 20 milligrams per day are standard. At this level, users can typically expect to experience the compound's characteristic strength and aggression benefits while minimizing the risk of severe side effects. Some protocols suggest starting at the lower end of this range (10 mg) and assessing tolerance before potentially increasing.

    Intermediate users, those with prior experience with the compound or with other potent orals, may operate in the 20 to 30 milligram per day range.     This represents the sweet spot for many experienced users-sufficient to deliver pronounced effects without crossing into the territory of dramatically elevated side effect risk.

    Advanced users, typically those with extensive AAS experience and a clear understanding of their personal tolerance, may push dosages to 30 to 40 milligrams per day. However, this range should be approached with extreme caution, as the risk of hepatotoxicity escalates significantly at higher doses.

    It bears emphasizing that these are supraphysiological doses far exceeding any legitimate medical application. The therapeutic doses used in clinical settings-typically 2 to 10 milligrams per day-are orders of magnitude lower than what bodybuilders employ. This disparity underscores the fundamentally different risk-reward calculus at play in performance enhancement contexts.

    The structural design of a Fluoxymesterone cycle reflects the compound's potent nature and its well-documented hepatotoxic profile. Cycles are characteristically short, typically spanning four to six weeks. Extended duration beyond this window substantially increases the risk of liver damage without conferring proportional additional benefits.

    A typical cycle might look something like this:

    Weeks 1-4:

    ●Fluoxymesterone at the chosen daily dosage (10-20 mg for beginners, 20-30 mg for intermediates)

    ●Concurrent administration of a base testosterone compound (e.g., testosterone enanthate at 300-500 mg per week) to maintain normal physiological function and mitigate suppression

    The inclusion of a testosterone base is considered prudent practice, as exogenous androgen administration suppresses endogenous testosterone production through feedback inhibition of pituitary luteinizing hormone (LH). Without exogenous testosterone to fill the gap, users would experience the symptoms of Testosterone deficiency, including lethargy, diminished libido, and mood disturbances.

    Some users choose to stack Fluoxymesterone with other non-aromatizing compounds during the cutting phase, though this approach requires careful consideration of cumulative hepatotoxicity. The compound is rarely used as a standalone in bodybuilding; it is typically incorporated into a broader cycle designed for contest preparation.

    The compound is also sometimes employed in a "pre-workout" capacity, with users taking a small dose (5-10 mg) approximately one hour before training to capitalize on the acute strength and aggression effects. However, this approach is less common and is generally as less effective than structured daily administration.

    Understanding the half-life of Fluoxymesterone is essential for optimizing dosing strategy. As noted previously, the compound's elimination half-life is approximately 9.2 to 9.5 hours. This relatively long half-life-at least by oral steroid standards-means that blood levels remain relatively stable throughout the day with once-daily administration.

    Some users nevertheless choose to split their daily dosage into two or three smaller administrations. The rationale is to achieve even more stable blood levels and potentially reduce the magnitude of peak concentrations that might contribute to side effects. While this approach is not strictly necessary given the pharmacokinetic profile, it is not unreasonable and may offer marginal benefits in terms of side effect mitigation.

    The half-life also informs the compound's detectability and the timing of its discontinuation prior to competition or drug testing. Users should be aware that the compound remains detectable in the system for a period extending beyond its half-life, and appropriate planning is required if testing is a concern.

    Post-cycle therapy is non-negotiable following any Fluoxymesterone cycle. The compound's suppression of endogenous testosterone production through negative feedback inhibition of LH and FSH means that natural testosterone levels will be significantly depressed upon discontinuation. Without intervention, recovery can be prolonged and accompanied by the full spectrum of hypogonadal symptoms.

    A standard PCT protocol following a Fluoxymesterone cycle typically involves a four-week course of selective estrogen receptor modulators (SERMs):

    Weeks 1-4 post-cycle:

    ●Clomiphene (Clomid): 50 mg per day

    ●Tamoxifen (Nolvadex): 20 mg per day

    These compounds stimulate the pituitary to increase LH and FSH production, thereby signaling the testes to resume endogenous testosterone synthesis. The combination of Clomid and Nolvadex is often preferred over either agent alone, as they work through complementary mechanisms to restore the hypothalamic-pituitary-gonadal axis.

    The importance of PCT cannot be overstated. The suppression induced by Fluoxymesterone is significant, and attempting to "ride out" the recovery period without pharmaceutical assistance is ill-advised. Users should allow adequate time for full recovery before initiating another cycle, with the duration of recovery typically proportional to the length and intensity of the preceding cycle.

    No discussion of Fluoxymesterone would be complete without acknowledging the substantial risks associated with its use. The compound is considered one of the most hepatotoxic oral steroids available. Liver damage, ranging from elevated liver enzymes to cholestatic hepatitis, peliosis hepatis, and hepatocellular neoplasms, has been documented with both prolonged use and high dosages. Signs of liver toxicity-dark urine, fatigue, appetite loss, abdominal pain, light-colored stools, vomiting, or jaundice-demand immediate discontinuation and medical evaluation.

    The compound also negatively impacts lipid profiles, reducing HDL cholesterol and increasing the ratio of total cholesterol to HDL. This cardiovascular risk factor, combined with the potential for elevated blood pressure and other androgenic effects, makes Fluoxymesterone a compound that demands respect and careful risk management.

Any needs, please contact us

Email: Jasonraws106@gmail.com

WhatsApp: +86-15572565525
Telegram: +86-15871669785

    Fluoxymesterone powder represents a highly specialized tool in the bodybuilder's arsenal-one valued not for mass-building but for its unparalleled ability to enhance strength, aggression, and muscular hardness during the most demanding phases of preparation. Its unique pharmacological profile, characterized by non-aromatization, potent androgenic activity, and significant hepatotoxicity, makes it suitable only for experienced users with clear goals and a comprehensive understanding of the associated risks. For those who fit this profile and approach the compound with appropriate caution and respect, Fluoxymesterone can deliver results that few other compounds can match.

Hot Tags: top-quality fluoxymesterone(halotestin)powder for bodybuilding cas:76-43-7, China top-quality fluoxymesterone(halotestin)powder for bodybuilding cas:76-43-7 manufacturers, suppliers, factory, Anabolic steroid drugs DHT, Letrozole Treating breast cancer, Oxymetholone, Testosterone Decanoate, Testosterone Propionate, Trenbolone Enanthate